Anti-inflammatory properties of HDL

被引：35

作者：

Ansell, BJ ^{[1
]}

Navab, M ^{[1
]}

Watson, KE ^{[1
]}

Fonarow, GC ^{[1
]}

Fogelman, AM ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol,Atherosclerosis Res Unit, Los Angeles, CA 90095 USA

来源：

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS | 2004年 / 5卷 / 04期

关键词：

HDL; LDL; lipid oxidation; inflammation;

D O I：

10.1023/B:REMD.0000045107.71895.b2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The formation of oxidized phospholipids within LDL activates the innate immune system. These oxidized phospholipids are generated from arachidonic acid via the lipoxygenase and myeloperoxidase pathways. Phospholipid oxidation may also affect reverse cholesterol transport. The HDL inflammatory index and measurements of the levels of lipid oxidation products in lipoproteins including products of the myeloperoxidase pathway may predict susceptibility to atherogenesis. The ability of ApoA-I and apoA-I mimetic peptides to reduce levels of oxidized lipids and also improve reverse cholesterol transport may have therapeutic potential.

引用

页码：351 / 358

页数：8

共 64 条

[1] Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].

Ansell, BJ ;

Navab, M ;

Hama, S ;

Kamranpour, N ;

Fonarow, G ;

Hough, G ;

Rahmani, S ;

Mottahedeh, R ;

Dave, R ;

Reddy, ST ;

Fogelman, AM .

CIRCULATION, 2003, 108 (22) :2751-2756

[2] REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT [J].

BADIMON, JJ ;

BADIMON, L ;

FUSTER, V .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1234-1241

[3] Oxidized HDL - The paradox-idation of lipoproteins [J].

Bergt, C ;

Oram, JF ;

Heinecke, JW .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1488-1490

[4] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].

BERLINER, JA ;

TERRITO, MC ;

SEVANIAN, A ;

RAMIN, S ;

KIM, JA ;

BAMSHAD, B ;

ESTERSON, M ;

FOGELMAN, AM .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266

[5] Innate and acquired immunity in atherogenesis [J].

Binder, CJ ;

Chang, MK ;

Shaw, PX ;

Miller, YI ;

Hartvigsen, K ;

Dewan, A ;

Witztum, JL .

NATURE MEDICINE, 2002, 8 (11) :1218-1226

[6] Pneumococcal vaccination decreases atherosclerotic lesion formation:: molecular mimicry between Streptococcus pneumoniae and oxidized LDL [J].

Binder, CJ ;

Hörkkö, S ;

Dewan, A ;

Chang, MK ;

Kieu, EP ;

Goodyear, CS ;

Shaw, PX ;

Palinski, W ;

Witztum, JL ;

Silverman, GJ .

NATURE MEDICINE, 2003, 9 (06) :736-743

[7] Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein [J].

Bisoendial, RJ ;

Hovingh, GK ;

Levels, JHM ;

Lerch, PG ;

Andresen, I ;

Hayden, MR ;

Kastelein, JJP ;

Stroes, ESG .

CIRCULATION, 2003, 107 (23) :2944-2948

[8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[9] Oxidized LDL-Induced injury and apoptosis in atherosclerosis - Potential roles for oxysterols [J].

Colles, SM ;

Maxson, JM ;

Carlson, SG ;

Chisolm, GM .

TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (3-4) :131-138

[10] MONOCYTES MAY AMPLIFY THEIR RECRUITMENT INTO INFLAMMATORY LESIONS BY INDUCING MONOCYTE CHEMOTACTIC PROTEIN [J].

CUSHING, SD ;

FOGELMAN, AM .

ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (01) :78-82

← 1 2 3 4 5 6 7 →